3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
549
Carcinoma, Non-Small-Cell Lung
506
Prostatic Neoplasms
335
Colorectal Neoplasms
268
Multiple Myeloma
267
Neoplasms
259
Leukemia, Myeloid, Acute
218
Squamous Cell Carcinoma of Head and Neck
213
Lung Neoplasms
206
Neoplasm Metastasis
204
Carcinoma, Hepatocellular
197
Triple Negative Breast Neoplasms
172
Melanoma
172
Pancreatic Neoplasms
171
Recurrence
153
Ovarian Neoplasms
151
Lymphoma
140
Sarcoma
132
Glioblastoma
132
Brain Neoplasms
132
Head and Neck Neoplasms
126
Carcinoma, Renal Cell
126
Leukemia, Lymphocytic, Chronic, B-Cell
125
Stomach Neoplasms
123
Lymphoma, Large B-Cell, Diffuse
123
Rectal Neoplasms
106
Precursor Cell Lymphoblastic Leukemia-Lymphoma
104
Uterine Cervical Neoplasms
101
Urinary Bladder Neoplasms
101
Myelodysplastic Syndromes
101
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Locally Advanced Pancreatic Cancer
×
1 year
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled